The federal government awarded $2 billion to two drugmakers to support development and manufacturing of an experimental drug and a potential vaccine against Covid-19.

Novavax Inc. said it would receive $1.6 billion from the federal government’ to fund clinical studies of its experimental coronavirus vaccine and establish large-scale manufacturing of doses. With the funding, Novavax said it would deliver 100 million doses of its vaccine, possibly by the end of this year.

Read More